Twist Bioscience CorporationTWSTNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank11
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-31.43
↓ 132% vs avg
Percentile
P11
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-13.55
Historical baseline
PeriodValueYoY Change
2025-31.43-123.9%
2024-14.03-154.6%
2023-5.51+27.7%
2022-7.63+76.9%
2021-33.07-49.6%
2020-22.10-257.6%
2019-6.18-31.1%
2018-4.71-3.9%
2017-4.54+27.7%
2016-6.28-